<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurosci</journal-id><journal-title>BMC Neuroscience</journal-title><issn pub-type="epub">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2202-8-11</article-id><article-id pub-id-type="pmid">17261189</article-id><article-id pub-id-type="doi">10.1186/1471-2202-8-11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Pigment epithelium-derived factor protects retinal ganglion cells</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Pang</surname><given-names>Iok-Hou</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>iok-hou.pang@alconlabs.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Zeng</surname><given-names>Hong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hong.zeng@alconlabs.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Fleenor</surname><given-names>Debra L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>debra.fleenor@alconlabs.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Clark</surname><given-names>Abbot F</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>abe.clark@alconlabs.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Alcon Research, Ltd., 6201 South Freeway, R3-24, Fort Worth, TX 76134, USA</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>29</day><month>1</month><year>2007</year></pub-date><volume>8</volume><fpage>11</fpage><lpage>11</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2202/8/11"/><history><date date-type="received"><day>6</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Pang et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Pang et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Pang Iok-Hou iok-hou.pang@alconlabs.com </dc:author><dc:title> Pigment epithelium-derived factor protects retinal ganglion cells </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Neuroscience 8(1): 11-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2202(2007)8:1&#x0003c;11&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2202</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Retinal ganglion cells (RGCs) are responsible for the transmission of visual signals to the brain. Progressive death of RGCs occurs in glaucoma and several other retinal diseases, which can lead to visual impairment and blindness. Pigment epithelium-derived factor (PEDF) is a potent antiangiogenic, neurotrophic and neuroprotective protein that can protect neurons from a variety of pathologic insults. We tested the effects of PEDF on the survival of cultured adult rat RGCs in the presence of glaucoma-like insults, including cytotoxicity induced by glutamate or withdrawal of trophic factors.</p></sec><sec><title>Results</title><p>Cultured adult rat RGCs exposed to glutamate for 3 days showed signs of cytotoxicity and death. The toxic effect of glutamate was concentration-dependent (EC<sub>50 </sub>= 31 &#x003bc;M). In the presence of 100 &#x003bc;M glutamate, RGC number decreased to 55 &#x000b1; 4% of control (mean &#x000b1; SEM, n = 76; P &#x0003c; 0.001). The glutamate effect was completely eliminated by MK801, an NMDA receptor antagonist. Trophic factor withdrawal also caused a similar loss of RGCs (54 &#x000b1; 4%, n = 60, P &#x0003c; 0.001). PEDF protected against both insults with EC<sub>50 </sub>values of 13.6 ng/mL (glutamate) and 3.4 ng/mL (trophic factor withdrawal), respectively. At 100 ng/mL, PEDF completely protected the cells from both insults. Inhibitors of the nuclear factor &#x003ba;B (NF&#x003ba;B) and extracellular signal-regulated kinases 1/2 (ERK1/2) significantly reduced the protective effects of PEDF.</p></sec><sec><title>Conclusion</title><p>We demonstrated that PEDF potently and efficaciously protected adult rat RGCs from glutamate- and trophic factor withdrawal-mediated cytotoxicity, via the activation of the NF&#x003ba;B and ERK1/2 pathways. The neuroprotective effect of PEDF represents a novel approach for potential treatment of retinopathies, such as glaucoma.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Glaucoma, one of the world's leading causes of visual impairment and blindness [<xref ref-type="bibr" rid="B1">1</xref>], is characterized by excavation of the optic nerve head and selective apoptotic loss of retinal ganglion cells (RGCs), resulting in a progressive decline in visual function. Elevated intraocular pressure is a major risk factor for the development and progression of glaucoma, although the loss of vision in glaucoma patients does not always correlate with intraocular pressure and lowering pressure sometimes does not completely impede the disease process [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Clearly, ocular hypertension is not the exclusive cause of glaucomatous retinopathy, and additional mechanisms likely play a role in the degeneration of RGCs. In the past years, several additional mechanisms for glaucomatous optic neuropathy and retinopathy have been proposed, including disrupted retrograde transport of neurotrophic factors, glutamate toxicity, retinal and/or optic nerve ischemia, and immune abnormality [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. These molecular events can eventually lead to apoptosis of RGCs. Unfortunately, the exact contribution of any of these factors in the pathogenesis of glaucomatous damage has not been unequivocally determined. It is probable that more than one etiology and multiple mechanisms are responsible in different patients and in different stages of glaucoma.</p><p>Despite our incomplete understanding of the disease processes and causes of RGC death, pharmacological protection of RGCs is under active investigation in ophthalmology research. Many neuroprotective strategies designed to prevent or delay the degeneration of RGCs are being evaluated, including some that are mechanism-specific. For example, glutamate receptor antagonists selectively protect against glutamate-induced cytotoxicity and may not have significant beneficial effects on other insults potentially involved in glaucoma. In contrast, other agents can protect RGCs against several toxic insults. These compounds, with their broader protective spectrum, are likely more useful as therapeutic agents for glaucoma. Pigment epithelium-derived factor (PEDF) appears to be one of these agents.</p><p>PEDF is a 50-kDa protein initially isolated from fetal human retinal pigment epithelial cells [<xref ref-type="bibr" rid="B8">8</xref>] and was later found to be expressed in various ocular tissues and cells, including the limbal region of the cornea and non-pigmented ciliary epithelial cells [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. PEDF is also found in the brain and spinal cord, as well as non-neuronal tissues, such as endothelial cells and osteoblasts [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. PEDF is a member of the serpin super-family of serine protease inhibitors [<xref ref-type="bibr" rid="B16">16</xref>]. However, unlike many serpins, PEDF does not inhibit serine proteases [<xref ref-type="bibr" rid="B17">17</xref>]. Instead, it exhibits potent antiangiogenic, neurotrophic and neuroprotective activities [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p><p>PEDF has broad neuroprotective effects in several neuronal cells and tissues. PEDF reduces glutamate-induced death of cerebellar granular cells, hippocampal neurons, and spinal cord motor neurons [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>]. It decreases post-axotomy death of motor neurons and completely prevents atrophy of the surviving neurons [<xref ref-type="bibr" rid="B20">20</xref>]. In the retina, PEDF improves the survival of cultured mixed retinal cells under oxidative stress [<xref ref-type="bibr" rid="B22">22</xref>]. It also protects against light-induced damage to photoreceptor cells <italic>in vivo </italic>[<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Intravitreal injection of recombinant PEDF or an adenoviral vector expressing PEDF was demonstrated to reduce retinal ischemia-induced RGC loss [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Although this animal model may not be relevant to glaucoma <italic>per se</italic>, the diverse protective effects of PEDF are nonetheless intriguing. We therefore tested PEDF in cultured adult rat RGCs to further characterize its potential protective effects against glaucoma-like insults.</p></sec><sec><title>Results</title><p>The adult rat retinal cell cultures using the method described herein contained RGC-enriched retinal neurons. More than 90% of the cells were positively labeled with neuron-specific enolase antibody, indicating that the majority of cells are neurons (data not shown). Approximately 20&#x02013;30% of these cells expressed Thy-1, and all Thy-1-positive cells were also positive for neurofilament-L (Figure <xref ref-type="fig" rid="F1">1</xref>). Both Thy-1 and neurofilament-L are selective cellular markers for RGC [<xref ref-type="bibr" rid="B26">26</xref>]. In contrast, cells in culture did not express marker proteins for other retinal cell types: they are negative for arrestin (photoreceptor), glial fibrillary acidic protein (GFAP; astroglia and M&#x000fc;ller cell), glutamine synthetase (M&#x000fc;ller cell), or ED1 (microglia). Less than 10% of the cells were labeled with the protein kinase C&#x003b1; antibody (rod bipolar cells) (data not shown).</p><p>Morphologically, the Thy-1-positive cells had the characteristic appearance of neurons. After 2&#x02013;3 days in culture, neurite outgrowth typically had 2&#x02013;4 main branches of approximately 20&#x02013;50 &#x003bc;m in length (Figure <xref ref-type="fig" rid="F2">2</xref>). As the culture period increased, the neurites lengthened and became more extensive, with most spanning greater than 100 &#x003bc;m in length after 7 or 11 days in culture (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><p>The RGCs appeared normal and healthy after 11 days in culture. For the sake of convenience, however our cell survival assays were performed using 3-day cultures. Under these conditions, there were 151 &#x000b1; 7 Thy-1-positive cells/well (mean &#x000b1; SEM, n = 124). Treatment with glutamate, an excitatory amino acid, damaged the cells. Glutamate (100 &#x003bc;M) caused significant changes in the morphology of many RGCs, including the loss of neurites, increased number of vacuoles in the cytoplasm, and compromised integrity of the plasma membrane (Figures <xref ref-type="fig" rid="F3">3A</xref> and <xref ref-type="fig" rid="F3">3B</xref>). In addition, there was formation of a greenish autofluorescence in the dying/dead RGCs, which, combined with the red fluorescent second antibody for Thy-1 detection, appeared yellow or orange (Figure <xref ref-type="fig" rid="F3">3B</xref>). Glutamate significantly (P &#x0003c; 0.001) reduced the number of RGCs in culture to 84 &#x000b1; 6 cells/well (n = 76), corresponding to a 42% loss of RGCs (35&#x02013;55% loss among studies) compared to control samples (Figure <xref ref-type="fig" rid="F3">3C</xref>). Glutamate toxicity was concentration-dependent with a calculated EC<sub>50 </sub>of 30.8 &#x003bc;M (Figure <xref ref-type="fig" rid="F3">3D</xref>). MK801, an antagonist for the N-methyl-D-aspartate (NMDA) glutamate receptor subtype, blocked the glutamate toxicity in a dose-dependent manner (Figure <xref ref-type="fig" rid="F3">3E</xref>). At 100 nM, MK801 completely prevented cell loss induced by 100 &#x003bc;M of glutamate. Agonists for non-NMDA glutamate receptors, such as kainate (100 &#x003bc;M, selective for ionotropic AMPA/kainate receptors), quisqualate (100 &#x003bc;M, activates both AMPA/kainate and metabotropic receptors), S-4-carboxy-3-hydroxyphenyl-glycine (50 &#x003bc;M, Group I metabotropic receptor agonist), L-carboxycyclopropylglycine (10 &#x003bc;M, Group II metabotropic receptor agonist), and L-(1)-2-amino-4-phosphonobutyrate (10 &#x003bc;M, Group III metabotropic receptor agonist) did not significantly affect RGC survival (data not shown). Glutamate toxicity appeared to be specific to the RGCs. At 100 &#x003bc;M, glutamate did not significantly affect Thy-1-negative cells in culture (data not shown).</p><p>Incubation of the RGCs with PEDF dose-dependently (EC<sub>50 </sub>= 13.6 ng/mL) protected against glutamate-induced toxicity. Complete protection was achieved by 100 ng/mL PEDF (Figure <xref ref-type="fig" rid="F4">4A</xref>). The same concentration of PEDF alone did not affect RGC survival or normal cell morphology. Although the PEDF receptor has not been well characterized, the biological effects of PEDF in other tissues and cell types are known to be mediated by the nuclear factor &#x003ba;B (NF&#x003ba;B) and/or extracellular signal-regulated kinases 1 and 2 (ERK1/2) cell signal transduction pathways [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. Therefore, we evaluated the effects of inhibitors for these pathways on the protective action of PEDF in our RGC culture system. As shown in Figure <xref ref-type="fig" rid="F4">4B</xref>, the PEDF-mediated RGC protection against glutamate toxicity was abolished by either NF&#x003ba;B-SN50, a cell-permeable NF&#x003ba;B inhibitor peptide, or ERK1/2 inhibitors, PD98059, SL327 and U0126. The effects of NF&#x003ba;B-SN50 and PD98059 were concentration-dependent (Figures <xref ref-type="fig" rid="F4">4C</xref> and <xref ref-type="fig" rid="F4">4D</xref>). At the highest concentrations tested, these two compounds alone did not affect RGC survival (data not shown).</p><p>In addition to glutamate, the survival of RGCs in culture was also sensitive to trophic factor withdrawal. Removal of brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor (bFGF), ciliary neurotrophic factor (CNTF), and forskolin from the culture media for three days caused a significant (P &#x0003c; 0.001) loss of RGCs, such that only 82 &#x000b1; 6 cells/well (n = 60) remained, which corresponded to an average 47% RGC loss compared to controls. PEDF effectively protected the RGC against this insult in a concentration-dependent manner with a calculated EC<sub>50 </sub>of 3.4 ng/mL (Figure <xref ref-type="fig" rid="F5">5A</xref>). The PEDF protective effect on trophic factor withdrawal was also fully blocked by NF&#x003ba;B-SN50 and ERK1/2 inhibitors (Figures <xref ref-type="fig" rid="F5">5B</xref>, <xref ref-type="fig" rid="F5">5C</xref>, and <xref ref-type="fig" rid="F5">5D</xref>), similar to its effect against glutamate toxicity.</p></sec><sec><title>Discussion</title><p>We have shown that glutamate was toxic to adult rat RGCs in culture, resulting in increased numbers of cells with aberrant morphology and decreased total numbers of surviving cells. This finding is similar to reports of glutamate toxicity in many other neurons. Glutamate is known to activate the NMDA, AMPA/kainite, and metabotropic glutamate receptors. Although RGCs express all of these receptor subtypes, the glutamate toxicity in our cultured RGC model is primarily mediated by NMDA receptors, because the NMDA receptor-specific antagonist MK801 blocked the response Agonists for the other glutamate receptors did not seem to be lethal to the cells. These results corroborate previous findings that the NMDA receptor is important for excitotoxicity in RGCs [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Nevertheless, because of controversies regarding glutamate-induced RGC toxicity, these data contradict other published findings. For example, some reported that both NMDA and kainite receptors contribute to RGC death (e.g., reference [<xref ref-type="bibr" rid="B29">29</xref>]), while others showed that only the kainite and not the NMDA receptor is responsible for RGC toxicity (e.g., reference [<xref ref-type="bibr" rid="B30">30</xref>]). Yet another group of investigators demonstrated that RGCs are resistant to glutamate or NMDA toxicity (e.g., reference [<xref ref-type="bibr" rid="B31">31</xref>]). The exact reasons for these disparities are not fully understood, but could be due to the different study conditions, which include the age and species of animals used, the presence or absence of other retinal cells in culture, or the duration and concentration of drug treatment. For example, in studies where excitotoxicity was not obvious, the incubation time was typically shorter (usually less than 24 h)[<xref ref-type="bibr" rid="B31">31</xref>] than that when excitotoxicity was observed (3 days in the current study)[<xref ref-type="bibr" rid="B27">27</xref>].</p><p>We also found that neurotrophic factors were essential for the survival of cultured RGCs. Numerous previous studies indicated that BDNF [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>], CNTF [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>], and bFGF [<xref ref-type="bibr" rid="B34">34</xref>] are essential survival factors. However, other trophic factors, such as nerve growth factor, glial cell line-derived neurotrophic factor, neurotrophins-3 and -4, have also been shown to be beneficial (reviewed in [<xref ref-type="bibr" rid="B35">35</xref>]). In the current cell culture, removal of BDNF, CNTF, and bFGF significantly reduced the survival of RGCs. Preliminary studies suggest that among these three trophic factors BDNF, in the presence of forskolin, was the most important for the health of the RGCs (unpublished observation).</p><p>Interestingly, not all RGCs were damaged by either type of insult in our culture system. Only about half of the RGCs were lost after either glutamate treatment or trophic factor withdrawal. Even with higher concentrations of glutamate or longer incubation times, we still did not observe a complete loss of the cells. Similar partial loss has been reported previously [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B40">40</xref>]. It is not clear if the neurons remaining after these insults differed biologically and functionally from those that perished. Dreyer and co-workers suggested that larger RGCs are more sensitive to glutamate toxicity [<xref ref-type="bibr" rid="B36">36</xref>]. However, we did not detect any size preferences of RGCs in susceptibility to either of the insults (unpublished observation).</p><p>PEDF protected cultured RGCs against both excitotoxicity and trophic factor withdrawal-induced cytotoxicity. Complete protection was observed at 100 ng/mL, a concentration shown to be neurotrophic and neuroprotective in other neurons [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. This neuroprotective concentration of PEDF appears relevant because PEDF concentration in human vitreous and aqueous humor was determined to be approximately 0.5 to 3 &#x003bc;g/mL [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. If RGCs in the retina are also exposed to similar levels of PEDF, PEDF may serve as one of the trophic factors that help sustain the health of RGCs. Interestingly, PEDF levels in aqueous humor of patients with advanced glaucoma are only about half of that of control eyes [<xref ref-type="bibr" rid="B48">48</xref>]. If PEDF levels in the vitreous and retina are also reduced in glaucomatous patients, the RGCs may be more susceptible to glaucomatous insults. The major sources of PEDF expression are in the retinal pigment epithelium, ciliary epithelium, and cornea [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. In addition, RGCs themselves also make PEDF [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. This locally produced PEDF may act as an autocrine effector and provide neurotrophic support for the RGCs.</p><p>Similar to other trophic factors, PEDF is expected to exert its biological effects by specifically binding and activating one or more receptors. However, PEDF receptors have not yet been fully characterized. Human retinoblastoma Y-79 cells, rat cerebellar granule neurons, cells in the ganglion cell layer, and inner segments of photoreceptor cells of bovine eyes have high affinity PEDF binding sites (K<sub>d </sub>= 3 nM) [<xref ref-type="bibr" rid="B50">50</xref>]. Most recently, a PEDF-binding protein, named PEDF-R, was identified from the pigment epithelium of human retina [<xref ref-type="bibr" rid="B51">51</xref>]. PEDF binds to this protein specifically and with high affinity. PEDF binding activates the protein and stimulates its phospholipase A<sub>2 </sub>enzymatic activity [<xref ref-type="bibr" rid="B51">51</xref>]. Currently, it is unclear whether PEDF-R is the only PEDF receptor subtype in the retina. Furthermore, its relationship to the cell signaling pathways responsible for the biological activity of PEDF is yet to be determined. Despite our incomplete knowledge of the PEDF receptor, the NF&#x003ba;B and ERK1/2 pathways appear to be involved in PEDF's activities [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. Our studies with cultured RGCs also indicate that both pathways are essential for the neuroprotective effects of PEDF. Inhibition of either pathway was sufficient to abolish the protective effects of PEDF. Activation of the transcription factor NF&#x003ba;B induces expression of other neurotrophic factors, such as BDNF and nerve growth factor, as well as antiapoptotic genes, including Bcl2, Bcl-x, and superoxide dismutase [<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>]. ERK1/2 activation leads to modulation of other kinases, phosphatases, transcription factors, and regulators of apoptosis [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>]. The identification of the down-stream effectors involved in the PEDF protection of RGCs awaits further studies.</p><p>The <italic>in vitro </italic>protective effects of PEDF suggest that PEDF may also protect RGCs <italic>in vivo</italic>. Indeed, intravitreal injection of PEDF significantly, albeit partially, protected against RGC loss and thinning of the inner retinal layers due to transient retinal ischemia in the rat [<xref ref-type="bibr" rid="B24">24</xref>]. Similar protection against the same insult and a reduction in apoptosis of the RGC were observed when adenoviral vector encoding PEDF was injected intravitreally [<xref ref-type="bibr" rid="B25">25</xref>]. Our results, together with these <italic>in vivo </italic>studies, suggest that PEDF is a potent and efficacious protectant for RGCs. PEDF should be a novel and effective therapeutic agent for glaucoma and other neuroretinopathies associated with RGC damage, provided obstacles to its delivery and metabolism can be overcome.</p></sec><sec><title>Conclusion</title><p>Pigment epithelium-derived factor potently and efficaciously protects cultured adult rat RGC against glutamate- or trophic factor withdrawal-induced cytotoxicity. The protective effects of PEDF were mediated by activation of NF&#x003ba;B and ERK1/2 pathways. This neuroprotective effect of PEDF may lead to a novel approach for the treatment of retinopathies, such as glaucoma.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Retinal cell culture</title><p>Handling of animals in this study was conducted in accordance with the policies for use of animals in neuroscience research established by the Society for Neuroscience and by the Animal Care and Use Committee in Alcon. Isolation of retinal cells was modified from a previously reported procedure [<xref ref-type="bibr" rid="B27">27</xref>]. Briefly, adult Sprague-Dawley rats were euthanized by CO<sub>2 </sub>asphyxiation and their eyes enucleated. The retina from each eye was dissected and incubated in a papain solution, containing 2 mg/mL papain (Sigma, St. Louis, MO), 0.4 mg/mL DL-cysteine (Sigma), and 0.4 mg/mL bovine serum albumin (Sigma) in Neurobasal medium (Gibco/Invitrogen, Carlsbad, CA), for 25 min at 37&#x000b0;C, then washed 3 times with RGC culture medium [<xref ref-type="bibr" rid="B56">56</xref>] (Neurobasal/B27 medium containing 100 units/mL penicillin (Sigma), 100 &#x003bc;g/mL streptomycin (Sigma), 1 mM pyruvate (Gibco/Invitrogen), 2 mM glutamine (Gibco/Invitrogen), 5 &#x003bc;g/mL insulin (Sigma), 100 &#x003bc;g/mL transferrin (Sigma), 100 &#x003bc;g/mL bovine serum albumin (Sigma), 60 ng/mL progesterone (Sigma), 16 &#x003bc;g/mL putrescine (Sigma), 40 ng/mL sodium selenite (Sigma), 40 ng/mL thyroxine (Sigma), 40 ng/mL tri-iodothyronine (Sigma), 50 ng/mL BDNF (Biosource, Camarillo, CA), 10 ng/mL CNTF (Biosource), 10 ng/mL bFGF (Biosource), 5 &#x003bc;M forskolin (Sigma), and 1% fetal calf serum (Atlas Biologicals, Fort Collins, CO)). Retinal pieces were triturated by passing through a fire-polished disposable glass pipette until cells were dispersed. Cell density in the suspension was assessed with a Coulter counter (Beckman Coulter, Fullerton, CA). 1 &#x000d7; 10<sup>6 </sup>to 3 &#x000d7; 10<sup>6 </sup>cells/well were placed onto poly-D-lysine- and laminin-coated 8-well chambered culture slides (surface area = 0.69 cm<sup>2</sup>/well; Becton Dickinson, Franklin Lakes, NJ) and cultured in 95% air/5% CO<sub>2 </sub>at 37&#x000b0;C.</p></sec><sec><title>Immunofluorescence</title><p>Cells were fixed with 3.7% formaldehyde in phosphate buffered saline (PBS)(EMD Chemicals, Gibbstown, NJ) at room temperature for 30 min, rinsed in PBS (Gibco) three times, and incubated for 1 h with PBS containing 0.02% saponin (Sigma) and the appropriate primary antibodies: Thy-1 (1:500; Chemicon, Temecula, CA), neurofilament-L (NF-L; 1:200; Serotec, Raleigh, NC), neuron-specific enolase (1:200; Chemicon), arrestin (1:200; Abcam, Cambridge, MA), protein kinase C&#x003b1; (1:250; Oxford Biomedical Research, Oxford, MI), GFAP (1:500; Chemicon), glutamine synthase (1:500; Sigma), or ED1 (1:100; Santa Cruz Biotechnology). The primary antibody was then removed, cells rinsed again, and incubated for 30 min with fluorescence-labeled secondary antibodies (1:300), Alexa fluor 594-labeled goat anti-mouse IgG (Invitrogen/Molecular Probes, Carlsbad, CA), Oregon green-labeled goat anti-rabbit IgG (Invitrogen/Molecular Probes), or Alexa fluor 488-labeled rabbit anti-goat IgG (Invitrogen/Molecular Probes). The cells were subsequently incubated with DAPI solution (100 ng/mL; Sigma) for 5 min to stain their nuclei. The slides were rinsed with distilled water, covered with Fluoromount G (Southern Biotech, Birmingham, AL) and a cover glass (VWR, Westchester, PA). The retinal cells was examined by fluorescence microscopy and digital images obtained.</p></sec><sec><title>Cytotoxic insults</title><p>For glutamate-induced toxicity studies, cells were pre-treated with vehicle or the indicated compounds for 30 min, followed by L-glutamate (0&#x02013;1000 &#x003bc;M) (Sigma) for 3 days. For trophic factor withdrawal studies, three trophic factors, bFGF, BDNF, and CNTF, together with forskolin, were removed from the culture medium. Cells were cultured in this medium for 3 days.</p></sec><sec><title>Quantification of cell survival</title><p>At the end of the incubation period, the cells were fixed then labeled for Thy-1 and DAPI. RGC survival was quantified by manually counting Thy-1-positive healthy cells in each well.</p></sec><sec><title>Statistical analysis</title><p>Cell counts are expressed as mean &#x000b1; SEM. Two-tailed Student's t-test was used to compare between two groups. One-way ANOVA followed by Dunnett's test was used to compare among three or more study groups. P &#x0003c; 0.05 is regarded as statistically significant.</p></sec></sec><sec><title>Authors' contributions</title><p>IHP contributed to the conception and design of the study, performed statistical analyses, and drafted the manuscript. HZ participated in the design of the study and carried out the cell assays. DLF participated in the design of the study, identified appropriate test agents, assisted in the interpretation of data, and helped to draft the manuscript. AFC participated in the conception and design of the study, assisted in the interpretation of data, and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This study was supported by Alcon Research, Ltd.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quigley</surname><given-names>HA</given-names></name><name><surname>Broman</surname><given-names>AT</given-names></name></person-group><article-title>The number of people with glaucoma worldwide in 2010 and 2020</article-title><source>Br J Ophthalmol</source><year>2006</year><volume>90</volume><fpage>262</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">16488940</pub-id><pub-id pub-id-type="doi">10.1136/bjo.2005.081224</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Buskirk</surname><given-names>EM</given-names></name><name><surname>Cioffi</surname><given-names>GA</given-names></name></person-group><article-title>Glaucomatous optic neuropathy</article-title><source>Am J Ophthalmol</source><year>1992</year><volume>113</volume><fpage>447</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">1558122</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumer</surname><given-names>RA</given-names></name><name><surname>Podos</surname><given-names>SM</given-names></name></person-group><article-title>The nerve of glaucoma!</article-title><source>Arch Ophthalmol</source><year>1994</year><volume>112</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8285890</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weih</surname><given-names>LM</given-names></name><name><surname>Nanjan</surname><given-names>M</given-names></name><name><surname>McCarty</surname><given-names>CA</given-names></name><name><surname>Taylor</surname><given-names>HR</given-names></name></person-group><article-title>Prevalence and predictors of open-angle glaucoma: results from the visual impairment project</article-title><source>Ophthalmology</source><year>2001</year><volume>108</volume><fpage>1966</fpage><lpage>1972</lpage><pub-id pub-id-type="pmid">11713063</pub-id><pub-id pub-id-type="doi">10.1016/S0161-6420(01)00799-0</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AF</given-names></name><name><surname>Pang</surname><given-names>IH</given-names></name></person-group><article-title>Advances in glaucoma therapeutics</article-title><source>Exp Opin Emerging Drugs</source><year>2002</year><volume>7</volume><fpage>141</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1517/14728214.7.1.141</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuehn</surname><given-names>MH</given-names></name><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>YH</given-names></name></person-group><article-title>Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies</article-title><source>Ophthalmol Clin North Am</source><year>2005</year><volume>18</volume><fpage>383</fpage><lpage>95, vi</lpage><pub-id pub-id-type="pmid">16054996</pub-id><pub-id pub-id-type="doi">10.1016/j.ohc.2005.04.002</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>IH</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Clark</surname><given-names>AF</given-names></name></person-group><article-title>The pathogenesis of retinal ganglia cell apoptosis induced by glaucoma</article-title><source>Chin J Ophthalmol</source><year>2004</year><volume>40</volume><fpage>495</fpage><lpage>499</lpage></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Chader</surname><given-names>GG</given-names></name><name><surname>Johnson</surname><given-names>LV</given-names></name></person-group><article-title>PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity</article-title><source>Exp Eye Res</source><year>1991</year><volume>53</volume><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">1936177</pub-id><pub-id pub-id-type="doi">10.1016/0014-4835(91)90248-D</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ortego</surname><given-names>J</given-names></name><name><surname>Escribano</surname><given-names>J</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name><name><surname>Coca Prados</surname><given-names>M</given-names></name></person-group><article-title>Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium. Synthesis and secretion into the aqueous humor</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>2759</fpage><lpage>2767</lpage><pub-id pub-id-type="pmid">8977492</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karakousis</surname><given-names>PC</given-names></name><name><surname>John</surname><given-names>SK</given-names></name><name><surname>Behling</surname><given-names>KC</given-names></name><name><surname>Surace</surname><given-names>EM</given-names></name><name><surname>Smith</surname><given-names>JE</given-names></name><name><surname>Hendrickson</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>WX</given-names></name><name><surname>Bennett</surname><given-names>J</given-names></name><name><surname>Milam</surname><given-names>AH</given-names></name></person-group><article-title>Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues</article-title><source>Mol Vis</source><year>2001</year><volume>7</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">11438800</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Behling</surname><given-names>KC</given-names></name><name><surname>Surace</surname><given-names>EM</given-names></name><name><surname>Bennett</surname><given-names>J</given-names></name></person-group><article-title>Pigment epithelium-derived factor expression in the developing mouse eye</article-title><source>Mol Vis</source><year>2002</year><volume>8</volume><fpage>449</fpage><lpage>454</lpage><pub-id pub-id-type="pmid">12447163</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Wada</surname><given-names>M</given-names></name><name><surname>Otsuji</surname><given-names>T</given-names></name><name><surname>Jo</surname><given-names>N</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name></person-group><article-title>Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>1168</fpage><lpage>1175</lpage><pub-id pub-id-type="pmid">11923262</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Barnstable</surname><given-names>CJ</given-names></name></person-group><article-title>Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor</article-title><source>Trends Mol Med</source><year>2003</year><volume>9</volume><fpage>244</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">12829012</pub-id><pub-id pub-id-type="doi">10.1016/S1471-4914(03)00074-1</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnstable</surname><given-names>CJ</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name></person-group><article-title>Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential</article-title><source>Prog Retin Eye Res</source><year>2004</year><volume>23</volume><fpage>561</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">15302351</pub-id><pub-id pub-id-type="doi">10.1016/j.preteyeres.2004.05.002</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tombran-Tink</surname><given-names>J</given-names></name></person-group><article-title>The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling</article-title><source>Front Biosci</source><year>2005</year><volume>10</volume><fpage>2131</fpage><lpage>2149</lpage><pub-id pub-id-type="pmid">15970483</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>FR</given-names></name><name><surname>Chader</surname><given-names>GJ</given-names></name><name><surname>Johnson</surname><given-names>LV</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name></person-group><article-title>Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><fpage>1526</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">8434014</pub-id><pub-id pub-id-type="doi">10.1073/pnas.90.4.1526</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becerra</surname><given-names>SP</given-names></name><name><surname>Sagasti</surname><given-names>A</given-names></name><name><surname>Spinella</surname><given-names>P</given-names></name><name><surname>Notario</surname><given-names>V</given-names></name></person-group><article-title>Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>25992</fpage><lpage>25999</lpage><pub-id pub-id-type="pmid">7592790</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.43.25992</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patricia Becerra</surname><given-names>S</given-names></name></person-group><article-title>Focus on Molecules: Pigment epithelium-derived factor (PEDF)</article-title><source>Exp Eye Res</source><year>2006</year><volume>82</volume><fpage>739</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">16364294</pub-id><pub-id pub-id-type="doi">10.1016/j.exer.2005.10.016</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniwaki</surname><given-names>T</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name><name><surname>Chader</surname><given-names>GJ</given-names></name><name><surname>Schwartz</surname><given-names>JP</given-names></name></person-group><article-title>Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture</article-title><source>J Neurochem</source><year>1995</year><volume>64</volume><fpage>2509</fpage><lpage>2517</lpage><pub-id pub-id-type="pmid">7760030</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houenou</surname><given-names>LJ</given-names></name><name><surname>D'Costa</surname><given-names>AP</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Turgeon</surname><given-names>VL</given-names></name><name><surname>Enyadike</surname><given-names>C</given-names></name><name><surname>Alberdi</surname><given-names>E</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name></person-group><article-title>Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons</article-title><source>J Comp Neurol</source><year>1999</year><volume>412</volume><fpage>506</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">10441236</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19990927)412:3&#x0003c;506::AID-CNE9&#x0003e;3.0.CO;2-E</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilak</surname><given-names>MM</given-names></name><name><surname>Corse</surname><given-names>AM</given-names></name><name><surname>Bilak</surname><given-names>SR</given-names></name><name><surname>Lehar</surname><given-names>M</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Kuncl</surname><given-names>RW</given-names></name></person-group><article-title>Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration</article-title><source>J Neuropathol Exp Neurol</source><year>1999</year><volume>58</volume><fpage>719</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">10411342</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Mrazek</surname><given-names>D</given-names></name><name><surname>Elias</surname><given-names>R</given-names></name><name><surname>McGinnis</surname><given-names>JF</given-names></name></person-group><article-title>Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death</article-title><source>J Neurosci Res</source><year>1999</year><volume>57</volume><fpage>789</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">10467250</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19990915)57:6&#x0003c;789::AID-JNR4&#x0003e;3.0.CO;2-M</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Elias</surname><given-names>R</given-names></name><name><surname>Sezate</surname><given-names>S</given-names></name><name><surname>Mrazek</surname><given-names>D</given-names></name><name><surname>McGinnis</surname><given-names>JF</given-names></name></person-group><article-title>In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>1646</fpage><lpage>1652</lpage><pub-id pub-id-type="pmid">11381073</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Jo</surname><given-names>N</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Mrazek</surname><given-names>D</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name></person-group><article-title>Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury</article-title><source>Curr Eye Res</source><year>2001</year><volume>22</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">11462162</pub-id><pub-id pub-id-type="doi">10.1076/ceyr.22.4.245.5506</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takita</surname><given-names>H</given-names></name><name><surname>Yoneya</surname><given-names>S</given-names></name><name><surname>Gehlbach</surname><given-names>PL</given-names></name><name><surname>Duh</surname><given-names>EJ</given-names></name><name><surname>Wei</surname><given-names>LL</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name></person-group><article-title>Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>4497</fpage><lpage>4504</lpage><pub-id pub-id-type="pmid">14507898</pub-id><pub-id pub-id-type="doi">10.1167/iovs.03-0052</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chidlow</surname><given-names>G</given-names></name><name><surname>Casson</surname><given-names>R</given-names></name><name><surname>Sobrado Calvo</surname><given-names>P</given-names></name><name><surname>Vidal Sanz</surname><given-names>M</given-names></name><name><surname>Osborne</surname><given-names>NN</given-names></name></person-group><article-title>Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">15947739</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>IH</given-names></name><name><surname>Wexler</surname><given-names>EM</given-names></name><name><surname>Nawy</surname><given-names>S</given-names></name><name><surname>DeSantis</surname><given-names>L</given-names></name><name><surname>Kapin</surname><given-names>MA</given-names></name></person-group><article-title>Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells</article-title><source>Invest Ophthalmol Vis Sci</source><year>1999</year><volume>40</volume><fpage>1170</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">10235550</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sucher</surname><given-names>NJ</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name><name><surname>Dreyer</surname><given-names>EB</given-names></name></person-group><article-title>Molecular basis of glutamate toxicity in retinal ganglion cells</article-title><source>Vision Res</source><year>1997</year><volume>37</volume><fpage>3483</fpage><lpage>3493</lpage><pub-id pub-id-type="pmid">9425525</pub-id><pub-id pub-id-type="doi">10.1016/S0042-6989(97)00047-3</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Heidinger</surname><given-names>V</given-names></name><name><surname>Picaud</surname><given-names>S</given-names></name><name><surname>Lambrou</surname><given-names>G</given-names></name><name><surname>Dreyfus</surname><given-names>H</given-names></name><name><surname>Sahel</surname><given-names>J</given-names></name><name><surname>Hicks</surname><given-names>D</given-names></name></person-group><article-title>Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>1096</fpage><lpage>1106</lpage><pub-id pub-id-type="pmid">11274091</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otori</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>JY</given-names></name><name><surname>Barnstable</surname><given-names>CJ</given-names></name></person-group><article-title>Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells</article-title><source>Invest Ophthalmol Vis Sci</source><year>1998</year><volume>39</volume><fpage>972</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">9579476</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ullian</surname><given-names>EM</given-names></name><name><surname>Barkis</surname><given-names>WB</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Diamond</surname><given-names>JS</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><article-title>Invulnerability of retinal ganglion cells to NMDA excitotoxicity</article-title><source>Mol Cell Neurosci</source><year>2004</year><volume>26</volume><fpage>544</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">15276156</pub-id><pub-id pub-id-type="doi">10.1016/j.mcn.2004.05.002</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mey</surname><given-names>J</given-names></name><name><surname>Thanos</surname><given-names>S</given-names></name></person-group><article-title>Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo</article-title><source>Brain Res</source><year>1993</year><volume>602</volume><fpage>304</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">8448673</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(93)90695-J</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyer Franke</surname><given-names>A</given-names></name><name><surname>Kaplan</surname><given-names>MR</given-names></name><name><surname>Pfrieger</surname><given-names>FW</given-names></name><name><surname>Barres</surname><given-names>BA</given-names></name></person-group><article-title>Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture</article-title><source>Neuron</source><year>1995</year><volume>15</volume><fpage>805</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">7576630</pub-id><pub-id pub-id-type="doi">10.1016/0896-6273(95)90172-8</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bahr</surname><given-names>M</given-names></name><name><surname>Vanselow</surname><given-names>J</given-names></name><name><surname>Thanos</surname><given-names>S</given-names></name></person-group><article-title>Ability of adult rat ganglion cells to regrow axons in vitro can be influenced by fibroblast growth factor and gangliosides</article-title><source>Neurosci Lett</source><year>1989</year><volume>96</volume><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">2784553</pub-id><pub-id pub-id-type="doi">10.1016/0304-3940(89)90057-8</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>HK</given-names></name><name><surname>So</surname><given-names>KF</given-names></name></person-group><article-title>Axonal regeneration of retinal ganglion cells: effect of trophic factors</article-title><source>Prog Retin Eye Res</source><year>2000</year><volume>19</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">10925243</pub-id><pub-id pub-id-type="doi">10.1016/S1350-9462(00)00009-4</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dreyer</surname><given-names>EB</given-names></name><name><surname>Pan</surname><given-names>ZH</given-names></name><name><surname>Storm</surname><given-names>S</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death</article-title><source>Neuroreport</source><year>1994</year><volume>5</volume><fpage>629</fpage><lpage>631</lpage><pub-id pub-id-type="pmid">7912962</pub-id><pub-id pub-id-type="doi">10.1097/00001756-199401000-00024</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitano</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Caprioli</surname><given-names>J</given-names></name></person-group><article-title>Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells</article-title><source>Exp Eye Res</source><year>1996</year><volume>63</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">8983955</pub-id><pub-id pub-id-type="doi">10.1006/exer.1996.0096</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>J</given-names></name><name><surname>Caprioli</surname><given-names>J</given-names></name><name><surname>Koseki</surname><given-names>Y</given-names></name></person-group><article-title>Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia</article-title><source>Arch Ophthalmol</source><year>1999</year><volume>117</volume><fpage>1524</fpage><lpage>1529</lpage><pub-id pub-id-type="pmid">10565522</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>A</given-names></name><name><surname>Otori</surname><given-names>Y</given-names></name><name><surname>Barnstable</surname><given-names>CJ</given-names></name></person-group><article-title>Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>3444</fpage><lpage>3450</lpage><pub-id pub-id-type="pmid">11006237</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Mishima</surname><given-names>HK</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Kashiwagi</surname><given-names>K</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Minamoto</surname><given-names>A</given-names></name><name><surname>Inaba</surname><given-names>T</given-names></name></person-group><article-title>Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells</article-title><source>Brain Res</source><year>2005</year><volume>1050</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">15979589</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2005.05.037</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniwaki</surname><given-names>T</given-names></name><name><surname>Hirashima</surname><given-names>N</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name><name><surname>Chader</surname><given-names>GJ</given-names></name><name><surname>Etcheberrigaray</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>JP</given-names></name></person-group><article-title>Pigment epithelium-derived factor protects cultured cerebellar granule cells against glutamate-induced neurotoxicity</article-title><source>J Neurochem</source><year>1997</year><volume>68</volume><fpage>26</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">8978706</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeCoster</surname><given-names>MA</given-names></name><name><surname>Schabelman</surname><given-names>E</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Bazan</surname><given-names>NG</given-names></name></person-group><article-title>Neuroprotection by pigment epithelial-derived factor against glutamate toxicity in developing primary hippocampal neurons</article-title><source>J Neurosci Res</source><year>1999</year><volume>56</volume><fpage>604</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">10374815</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19990615)56:6&#x0003c;604::AID-JNR6&#x0003e;3.0.CO;2-B</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>JI</given-names></name><name><surname>Tombran-Tink</surname><given-names>J</given-names></name><name><surname>Hykin</surname><given-names>PG</given-names></name><name><surname>Gregor</surname><given-names>ZJ</given-names></name><name><surname>Cree</surname><given-names>IA</given-names></name></person-group><article-title>Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles</article-title><source>Exp Eye Res</source><year>2006</year><volume>82</volume><fpage>798</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">16324700</pub-id><pub-id pub-id-type="doi">10.1016/j.exer.2005.10.002</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funatsu</surname><given-names>H</given-names></name><name><surname>Yamashita</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Mimura</surname><given-names>T</given-names></name><name><surname>Eguchi</surname><given-names>S</given-names></name><name><surname>Noma</surname><given-names>H</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name></person-group><article-title>Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema</article-title><source>Ophthalmology</source><year>2006</year><volume>113</volume><fpage>294</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">16406543</pub-id><pub-id pub-id-type="doi">10.1016/j.ophtha.2005.10.030</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duh</surname><given-names>EJ</given-names></name><name><surname>Yang</surname><given-names>HS</given-names></name><name><surname>Haller</surname><given-names>JA</given-names></name><name><surname>De Juan</surname><given-names>E</given-names></name><name><surname>Humayun</surname><given-names>MS</given-names></name><name><surname>Gehlbach</surname><given-names>P</given-names></name><name><surname>Melia</surname><given-names>M</given-names></name><name><surname>Pieramici</surname><given-names>D</given-names></name><name><surname>Harlan</surname><given-names>JB</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><article-title>Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>137</volume><fpage>668</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">15059706</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9394(03)01422-3</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Nishikawa</surname><given-names>M</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Mitsuma</surname><given-names>Y</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name></person-group><article-title>Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy</article-title><source>Am J Ophthalmol</source><year>2002</year><volume>134</volume><fpage>348</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">12208245</pub-id><pub-id pub-id-type="doi">10.1016/S0002-9394(02)01568-4</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spranger</surname><given-names>J</given-names></name><name><surname>Osterhoff</surname><given-names>M</given-names></name><name><surname>Reimann</surname><given-names>M</given-names></name><name><surname>Mohlig</surname><given-names>M</given-names></name><name><surname>Ristow</surname><given-names>M</given-names></name><name><surname>Francis</surname><given-names>MK</given-names></name><name><surname>Cristofalo</surname><given-names>V</given-names></name><name><surname>Hammes</surname><given-names>HP</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Boulton</surname><given-names>M</given-names></name><name><surname>Pfeiffer</surname><given-names>AF</given-names></name></person-group><article-title>Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>2641</fpage><lpage>2645</lpage><pub-id pub-id-type="pmid">11723044</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>N</given-names></name><name><surname>Matsuoka</surname><given-names>M</given-names></name><name><surname>Imaizumi</surname><given-names>M</given-names></name><name><surname>Arichi</surname><given-names>M</given-names></name><name><surname>Matsumura</surname><given-names>M</given-names></name></person-group><article-title>Decreased levels of pigment epithelium-derived factor in eyes with neuroretinal dystrophic diseases</article-title><source>Am J Ophthalmol</source><year>2004</year><volume>137</volume><fpage>1129</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">15183804</pub-id><pub-id pub-id-type="doi">10.1016/j.ajo.2003.11.080</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Lang</surname><given-names>G</given-names></name><name><surname>Volpert</surname><given-names>O</given-names></name><name><surname>Jehle</surname><given-names>PM</given-names></name><name><surname>Kurkhaus</surname><given-names>A</given-names></name><name><surname>Rosinger</surname><given-names>S</given-names></name><name><surname>Lang</surname><given-names>GK</given-names></name><name><surname>Bouck</surname><given-names>N</given-names></name></person-group><article-title>Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy</article-title><source>Diabetologia</source><year>2003</year><volume>46</volume><fpage>394</fpage><lpage>400</lpage><pub-id pub-id-type="pmid">12687338</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alberdi</surname><given-names>E</given-names></name><name><surname>Aymerich</surname><given-names>MS</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name></person-group><article-title>Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>31605</fpage><lpage>31612</lpage><pub-id pub-id-type="pmid">10531367</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.44.31605</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Notari</surname><given-names>L</given-names></name><name><surname>Baladron</surname><given-names>V</given-names></name><name><surname>Aroca Aguilar</surname><given-names>JD</given-names></name><name><surname>Balko</surname><given-names>N</given-names></name><name><surname>Heredia</surname><given-names>R</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Notario</surname><given-names>PM</given-names></name><name><surname>Saravanamuthu</surname><given-names>S</given-names></name><name><surname>Nueda</surname><given-names>ML</given-names></name><name><surname>Sanchez Sanchez</surname><given-names>F</given-names></name><name><surname>Escribano</surname><given-names>J</given-names></name><name><surname>Laborda</surname><given-names>J</given-names></name><name><surname>Becerra</surname><given-names>SP</given-names></name></person-group><article-title>Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>38022</fpage><lpage>38037</lpage><pub-id pub-id-type="pmid">17032652</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M600353200</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Courtois</surname><given-names>G</given-names></name></person-group><article-title>The NF-kappaB signaling pathway in human genetic diseases</article-title><source>Cell Mol Life Sci</source><year>2005</year><volume>62</volume><fpage>1682</fpage><lpage>1691</lpage><pub-id pub-id-type="pmid">15924263</pub-id><pub-id pub-id-type="doi">10.1007/s00018-005-5031-5</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Kral</surname><given-names>JG</given-names></name></person-group><article-title>The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy</article-title><source>J Surg Res</source><year>2005</year><volume>123</volume><fpage>158</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">15652965</pub-id><pub-id pub-id-type="doi">10.1016/j.jss.2004.06.006</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Seger</surname><given-names>R</given-names></name></person-group><article-title>The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions</article-title><source>Growth Factors</source><year>2006</year><volume>24</volume><fpage>21</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">16393692</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rubinfeld</surname><given-names>H</given-names></name><name><surname>Seger</surname><given-names>R</given-names></name></person-group><article-title>The ERK cascade: a prototype of MAPK signaling</article-title><source>Mol Biotechnol</source><year>2005</year><volume>31</volume><fpage>151</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">16170216</pub-id><pub-id pub-id-type="doi">10.1385/MB:31:2:151</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barres</surname><given-names>BA</given-names></name><name><surname>Silverstein</surname><given-names>BE</given-names></name><name><surname>Corey</surname><given-names>DP</given-names></name><name><surname>Chun</surname><given-names>LL</given-names></name></person-group><article-title>Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning</article-title><source>Neuron</source><year>1988</year><volume>1</volume><fpage>791</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">2908449</pub-id><pub-id pub-id-type="doi">10.1016/0896-6273(88)90127-4</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Identification of cultured adult rat RGCs</bold>. Cultured cells were co-labeled with anti-Thy-1 antibody (A), anti-NF-L antibody (B), and DAPI (C). (D) A digitally merged image simultaneously represents all three fluorescent labels. (E) The corresponding phase-contrast image. The cells were cultured for 3 days under control conditions. Scale bar = 50 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-8-11-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Morphology of cultured adult rat RGCs</bold>. The cells, cultured for 3 (A &#x00026; B), 7 (C &#x00026; D), and 11 (E &#x00026; F) days, were labeled with anti-Thy-1 antibody (red) and DAPI nuclear stain (blue). (B), (D), are (F) are the corresponding phase-contrast images. Scale bar = 50 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-8-11-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Effect of glutamate on RGC morphology and survival</bold>. Cells were treated with glutamate or vehicle for 3 days. (A and B) Morphology of RGCs with glutamate (100 &#x003bc;M) treatment. (A) The cells were labeled with anti-Thy-1 antibody (red) and DAPI nuclear stain (blue). (B) The corresponding phase-contrast image. (C) Effect of glutamate (100 &#x003bc;M) on RGC survival (n = 76). *** represents P &#x0003c; 0.001 vs. the control group by Student's t-test. (D) Concentration-dependent toxicity of glutamate on cultured RGCs (n = 6). * represents P &#x0003c; 0.05 vs. the control group by One-way ANOVA then Dunnett's test. (E) Effect of MK801 on glutamate-induced RGC toxicity. Cells were treated with the indicated concentrations of MK801 in the presence of 100 &#x003bc;M of glutamate (n = 6). * represents P &#x0003c; 0.05 vs. the glutamate alone group by One-way ANOVA then Dunnett's test. Cell survival in (C), (D), and (E) was assessed by manually counting the Thy-1-positive cells. Data are presented as mean &#x000b1; SEM.</p></caption><graphic xlink:href="1471-2202-8-11-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Protective effect of PEDF against glutamate-induced RGC toxicity</bold>. (A) Cells were treated with the indicated concentrations of PEDF in the presence or absence of 100 &#x003bc;M of glutamate (n = 6). (B) Effects of various compounds on PEDF protection against excitotoxicity. Numbers on the bars represent sample sizes. (C and D) Concentration-dependent reversal of the PEDF protection by NF&#x003ba;B inhibitor NF&#x003ba;B-SN50 and ERK1/2 inhibitor PD98059, respectively. * represents P &#x0003c; 0.05 vs. the respective control group by One-way ANOVA then Dunnett's test. Glu = glutamate.</p></caption><graphic xlink:href="1471-2202-8-11-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Protective effect of PEDF against trophic factor withdrawal-induced RGC toxicity</bold>. (A) Cells were treated with the indicated concentrations of PEDF in the presence or absence of trophic factors (n = 6). (B) Effects of various compounds on the PEDF protection against trophic factor withdrawal-induced cytotoxicity. Numbers on the bars represent sample sizes. TFW = trophic factor withdrawal. (C and D) Concentration-dependent reversal of the PEDF protection by NF&#x003ba;B inhibitor NF&#x003ba;B-SN50 and ERK1/2 inhibitor PD98059, respectively. Three trophic factors, bFGF, BDNF, and CNTF were removed from the culture medium in the trophic factor withdrawal group. * represents P &#x0003c; 0.05 vs. the respective control group by One-way ANOVA then Dunnett's test.</p></caption><graphic xlink:href="1471-2202-8-11-5"/></fig></sec></back></article> 